Trade Summary

3 days ago, Burnett Patrick, serving as See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,697 shares at $27.00 per share, for a total transaction value of $45,819.00. Following this transaction, Burnett Patrick now holds 117,592 shares of ARQT.

This sale represents a 1.42% decrease in Burnett Patrick's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, August 19, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 21, 2026 at 4:08 PM ET, 2 days after the trade was made.

Arcutis Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.